Clinical studies recruiting near Newark

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Oxytocin Rest to Reduce Cesarean Delivery
NA · ChristianaCare Health System · Christiana Care Health Services · NCT06268431 A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · 31786, New Jersey Medical School Clinical Research Center CR · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441 Virtual Cycling Environments for Persons With Parkinson Disease
NA · School of Health Professions · Rutgers, The State University of New Jersey · NCT04804202 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Newark Beth Israel Medical Center · National Cancer Institute (NCI) · NCT05099003 Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women
Phase 4 · University of Delaware · University of Delaware · NCT06745466 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Helen F Graham Cancer Center · NRG Oncology · NCT05624996 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Newark Beth Israel Medical Center · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Newark Beth Israel Medical Center · National Cancer Institute (NCI) · NCT05691478 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Rutgers New Jersey Medical School ( Site 0010) · Merck Sharp & Dohme LLC · NCT07044297 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Medical Oncology and Hematology Consultants · Agendia · NCT03053193 Non-Invasive Preeclampsia Screening and Biobank
Phase N/A · Delaware Center for Maternal and Fetal Medicine · Sequenom, Inc. · NCT06643741 Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children
Phase 2 · University Hospital · Rutgers, The State University of New Jersey · NCT07188779 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Newark Beth Israel Medical Center · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Medical Oncology Hematology Consultants, PA · Pfizer · NCT07144280 Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Phase 2 · Medical Oncology Hematology Consultants · SCRI Development Innovations, LLC · NCT05972135 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Helen F Graham Cancer Center · SWOG Cancer Research Network · NCT06769126 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Helen F Graham Cancer Center · NRG Oncology · NCT05946213 Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult
Phase 3 · Rutgers New Jersey Medical School - Newark /ID# 264187 · AbbVie · NCT06575192 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Helen F Graham Cancer Center · NRG Oncology · NCT05174169 Western Diet on Cardiometabolic and Immune Function
NA · University of Delaware · University of Delaware · NCT06528977 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Helen F Graham Cancer Center · Alliance for Clinical Trials in Oncology · NCT06632327 Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · Christiana Care Hospital - Helen F Graham Cancer Center · Schrödinger, Inc. · NCT05544019 Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Phase N/A · Reproductive Associates of Delaware (RAD) · Aspira Women's Health · NCT05245695 Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder
Phase 1 · Rutgers School of Health Professions · Rutgers, The State University of New Jersey · NCT06642181 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Helen F Graham Cancer Center · Alliance for Clinical Trials in Oncology · NCT06876714 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Medical Oncology Hematology Consultants (MOHC) ( Site 8007) · Merck Sharp & Dohme LLC · NCT06890884 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785

Look up another city

Look up another condition